Paper5337697
Introduction to the biochemistry of D-arabinosyl nucleosides.
Cohen SS. Prog Nucleic Acid Res Mol Biol, 1966. Cited by 124 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Introduction to the biochemistry of D-arabinosyl nucleosides. Papers, record 5337697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5337697
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nucleosides | Major topic |
| Arabinose | |
| Chemistry, Organic | |
| Culture Techniques | |
| Escherichia coli | |
| Nucleotides | |
| Nucleotidyltransferases | |
| Organic Chemistry Phenomena |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38535455 | Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies. | Mar Drugs | 2024 | https://conductscience.org/library/papers/38535455 | PubMed |
| 37243232 | Hydrogen Bonding (Base Pairing) in Antiviral Activity. | Viruses | 2023 | https://conductscience.org/library/papers/37243232 | PubMed |
| 31633499 | An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia. | Anticancer Drugs | 2020 | https://conductscience.org/library/papers/31633499 | PubMed |
| 27281742 | Approved Antiviral Drugs over the Past 50 Years. | Clin Microbiol Rev | 2016 | https://conductscience.org/library/papers/27281742 | PubMed |
| 22920396 | The clinically relevant pharmacogenomic changes in acute myelogenous leukemia. | Pharmacogenomics | 2012 | https://conductscience.org/library/papers/22920396 | PubMed |
| 15825318 | Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15825318 | PubMed |
| 7525187 | Evolution of the arabinosides and the pharmacology of fludarabine. | Drugs | 1994 | https://conductscience.org/library/papers/7525187 | PubMed |
| 7062908 | Effect of arabinosyl cytosine on the level of DNA polymerase and thymidine kinase activity in PHA-stimulated human tonsillar lymphocytes. | Mol Cell Biochem | 1982 | https://conductscience.org/library/papers/7062908 | PubMed |
| 6998693 | Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. | Drugs | 1980 | https://conductscience.org/library/papers/6998693 | PubMed |
| 6651280 | Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6651280 | PubMed |
| 6255863 | Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6255863 | PubMed |
| 6166246 | Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6166246 | PubMed |
| 5699806 | Repair replication and degradation of bromouracil-substituted DNA in mammalian cells after irradiation with ultraviolet light. | Biophys J | 1968 | https://conductscience.org/library/papers/5699806 | PubMed |
| 5695537 | Characterization of an inhibitor for Lactobacillus bulgaricus in tomato juice. | Appl Microbiol | 1968 | https://conductscience.org/library/papers/5695537 | PubMed |
| 5244747 | Behavioral and biochemical effects of intracranial injection of cytosine arabinoside in goldfish. | Proc Natl Acad Sci U S A | 1968 | https://conductscience.org/library/papers/5244747 | PubMed |
| 4981070 | Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance. | J Cell Biol | 1969 | https://conductscience.org/library/papers/4981070 | PubMed |
| 4919542 | Pyrimidine metabolism in microorganisms. | Bacteriol Rev | 1970 | https://conductscience.org/library/papers/4919542 | PubMed |
| 4840442 | Thermal inactivation as a means of inhibiting the serum-associated deamination of 9-beta-D Arabinofuranosyladenine in tissue culture media. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4840442 | PubMed |
| 4790562 | Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4790562 | PubMed |
| 4595569 | DNA repair in Escherichia coli mutants deficient in DNA polymerases I, II and-or 3. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4595569 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5337697
GET https://conductscience.org/api/papers/v1/5337697/cited_by?page=2